Trial Profile
The optimal dose period of indisetron tablets for preventing chemotherapy-induced nausea and vomiting (CINV) induced by mFOLFOX6.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2013
Price :
$35
*
At a glance
- Drugs Indisetron (Primary) ; Dexamethasone
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 09 Mar 2011 New trial record
- 22 Jan 2011 Results presented at the 2011 Gastrointestinal Cancers Symposium.